Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased

Pulmonx (LUNG) Long-Term Debt Repayments (2022 - 2025)

Pulmonx has reported Long-Term Debt Repayments over the past 4 years, most recently at $1000.0 for Q3 2025.

Quarterly Long-Term Debt Repayments changed N/A to $1000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $98000.0 through Sep 2025, up 8.89% year-over-year, with the annual reading at $95000.0 for FY2024, 1.06% up from the prior year.
Long-Term Debt Repayments was $1000.0 for Q3 2025 at Pulmonx, down from $48000.0 in the prior quarter.
Over five years, Long-Term Debt Repayments peaked at $49000.0 in Q4 2024 and troughed at $1000.0 in Q3 2025.
The 4-year median for Long-Term Debt Repayments is $47000.0 (2023), against an average of $37600.0.
Year-over-year, Long-Term Debt Repayments increased 9.3% in 2023 and then grew 4.26% in 2024.
A 4-year view of Long-Term Debt Repayments shows it stood at $43000.0 in 2022, then rose by 9.3% to $47000.0 in 2023, then increased by 4.26% to $49000.0 in 2024, then tumbled by 97.96% to $1000.0 in 2025.
Per Business Quant, the three most recent readings for LUNG's Long-Term Debt Repayments are $1000.0 (Q3 2025), $48000.0 (Q2 2025), and $49000.0 (Q4 2024).